[Testosterone radioimmunoassay with 125I-testosterone kits].
作者信息
Kawamura J, Okada K, Yoshida O, Kousaka T, Torizuka K
出版信息
Kaku Igaku. 1986 Apr;23(4):431-8.
PMID:3735786
Abstract
摘要
相似文献
1
[Testosterone radioimmunoassay with 125I-testosterone kits].使用125I-睾酮试剂盒进行睾酮放射免疫测定
Kaku Igaku. 1986 Apr;23(4):431-8.
2
[Testosterone radioimmunoassay with 125I-testosterone kit (author's transl)].使用125I-睾酮试剂盒的睾酮放射免疫测定法（作者译）
Kaku Igaku. 1979 Aug;16(5):747-52.
3
[Fundamental and clinical evaluation of 125I-testosterone radioimmunoassay kit "Eiken" (author's transl)].“荣研”125I-睾酮放射免疫分析试剂盒的基础与临床评价（作者译）
Horumon To Rinsho. 1979 May;27(5):527-31.
4
Incomplete testosterone suppression in prostate cancer.前列腺癌中睾酮抑制不完全。
N Engl J Med. 2010 Nov 11;363(20):1976. doi: 10.1056/NEJMc1010187.
5
[Significance of serum testosterone and LH determination in the hormonal therapy of prostatic cancer].
Rozhl Chir. 1978 Dec;57(12):805-12.
6
Role of testosterone in managing advanced prostate cancer.睾酮在治疗晚期前列腺癌中的作用。
Urology. 2012 Oct;80(4):754-62. doi: 10.1016/j.urology.2012.05.006. Epub 2012 Jul 13.
7
[Fundamental evaluation of 125I-testosterone radioimmunoassay kit "Eiken" (author's transl)].“荣研”125I-睾酮放射免疫分析试剂盒的基础评价（作者译）
Horumon To Rinsho. 1981 Nov;29(11):1413-5.
8
Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?在接受联合雄激素阻断治疗的转移性前列腺癌患者中，睾酮水平是否具有预后意义？
Int J Urol. 2015 Jan;22(1):132-3. doi: 10.1111/iju.12623. Epub 2014 Sep 22.
9
[Radioimmunoassay for testosterone using 125I-testosterone as radioligand].以125I-睾酮作为放射性配体的睾酮放射免疫测定法
Horumon To Rinsho. 1983 May;31(5):463-5.
10
Androgen deprivation therapy for prostate cancer.前列腺癌的雄激素剥夺疗法。
J Urol. 2007 Oct;178(4 Pt 1):1148. doi: 10.1016/j.juro.2007.07.066. Epub 2007 Aug 14.
引用本文的文献
1
Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N-(2-methyl-2-propyl)-3-oxo-4-aza-5 alpha-androst-1-ene-17 beta-carboxamide, a new type of specific competitive inhibitor of testosterone 5 alpha-reductase, in volunteers.新型睾酮5α-还原酶特异性竞争性抑制剂N-(2-甲基-2-丙基)-3-氧代-4-氮杂-5α-雄甾-1-烯-17β-甲酰胺在志愿者单次及多次口服后的药代动力学及生化效应
Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):15-21. doi: 10.1007/BF03189869.
Zotero 插件